Evaluating Novel Biomarkers for Personalized Medicine
Standard and cutting-edge biomarkers used for the diagnosis and evaluation of different illnesses will be covered in this Special Issue. Emphasis will be placed on personalized medicine, since this innovative strategy enables healthcare professionals to identify the most effective therapies for each...
Uloženo v:
| Médium: | Online |
|---|---|
| Jazyk: | angličtina |
| Vydáno: |
MDPI - Multidisciplinary Digital Publishing Institute
2024
|
| Témata: | |
| On-line přístup: | ONIX_20240514_9783725806928_426 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| _version_ | 1869528295581679616 |
|---|---|
| collection | Directory of Open Access Books |
| description | Standard and cutting-edge biomarkers used for the diagnosis and evaluation of different illnesses will be covered in this Special Issue. Emphasis will be placed on personalized medicine, since this innovative strategy enables healthcare professionals to identify the most effective therapies for each patient using diagnostic tests and biomarkers.Evidence-based findings indicate that many medications are unsuccessful for some individuals; as such, this method is crucial. Healthcare professionals can create individual preventative plans and treatment plans by considering the patient's medical history, as well as biomarkers throughout the diagnosis process. This strategy benefits patients and the healthcare system, according to several cost-effectiveness studies. Treatments that are customized for each patient offer both medical and financial benefits, making them not only essential for patients and physicians, but also welcomed by regulatory agencies as well as insurance providers. |
| format | Online |
| id | doab-20.500.12854ir-137830 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1378302024-05-14T14:37:25Z Evaluating Novel Biomarkers for Personalized Medicine Drugan, Tudor Leucuta, Daniel inflammation monocyte GLUT1 PET-CT scan non-small cell lung cancer prognosis survival gastric cancer neopterin chitotriosidase stadialisation resectability intrahepatic cholangiocarcinoma hepatocellular carcinoma secondary tumor needle biopsy immunohistochemistry CK7 intratumoral immune cells saliva biomarkers anti-epileptic drugs therapeutic drug monitoring seizure epilepsy histopathology biomarker severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease (COVID-19) autopsy lung multiple sclerosis neurodegeneration clinically isolated syndrome optical coherence tomography retinal fiber layers ganglion cell layer posterior pole analysis macular retinal segmentation pulse wave velocity chronic kidney disease malnutrition inflammation triiodothyronine prolactin COPD COVID-19 SARS-CoV-2 infection predictive model mortality intensive care unit mechanical ventilation adropin kidney transplant recipients nutritional status body composition inflammatory markers machine learning transcatheter aortic valve replacement nasopharyngeal cancer tooth extraction glucose C-reactive protein albumin n/a thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology::MKGW Psychopharmacology Standard and cutting-edge biomarkers used for the diagnosis and evaluation of different illnesses will be covered in this Special Issue. Emphasis will be placed on personalized medicine, since this innovative strategy enables healthcare professionals to identify the most effective therapies for each patient using diagnostic tests and biomarkers.Evidence-based findings indicate that many medications are unsuccessful for some individuals; as such, this method is crucial. Healthcare professionals can create individual preventative plans and treatment plans by considering the patient's medical history, as well as biomarkers throughout the diagnosis process. This strategy benefits patients and the healthcare system, according to several cost-effectiveness studies. Treatments that are customized for each patient offer both medical and financial benefits, making them not only essential for patients and physicians, but also welcomed by regulatory agencies as well as insurance providers. 2024-05-14T14:37:16Z 2024-05-14T14:37:16Z 2024 book ONIX_20240514_9783725806928_426 9783725806928 9783725806911 https://directory.doabooks.org/handle/20.500.12854/137830 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/9068 https://mdpi.com/books/pdfview/book/9068 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-0691-1 10.3390/books978-3-7258-0691-1 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725806928 9783725806911 172 open access |
| spellingShingle | inflammation monocyte GLUT1 PET-CT scan non-small cell lung cancer prognosis survival gastric cancer neopterin chitotriosidase stadialisation resectability intrahepatic cholangiocarcinoma hepatocellular carcinoma secondary tumor needle biopsy immunohistochemistry CK7 intratumoral immune cells saliva biomarkers anti-epileptic drugs therapeutic drug monitoring seizure epilepsy histopathology biomarker severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease (COVID-19) autopsy lung multiple sclerosis neurodegeneration clinically isolated syndrome optical coherence tomography retinal fiber layers ganglion cell layer posterior pole analysis macular retinal segmentation pulse wave velocity chronic kidney disease malnutrition inflammation triiodothyronine prolactin COPD COVID-19 SARS-CoV-2 infection predictive model mortality intensive care unit mechanical ventilation adropin kidney transplant recipients nutritional status body composition inflammatory markers machine learning transcatheter aortic valve replacement nasopharyngeal cancer tooth extraction glucose C-reactive protein albumin n/a thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology::MKGW Psychopharmacology Evaluating Novel Biomarkers for Personalized Medicine |
| title | Evaluating Novel Biomarkers for Personalized Medicine |
| title_full | Evaluating Novel Biomarkers for Personalized Medicine |
| title_fullStr | Evaluating Novel Biomarkers for Personalized Medicine |
| title_full_unstemmed | Evaluating Novel Biomarkers for Personalized Medicine |
| title_short | Evaluating Novel Biomarkers for Personalized Medicine |
| title_sort | evaluating novel biomarkers for personalized medicine |
| topic | inflammation monocyte GLUT1 PET-CT scan non-small cell lung cancer prognosis survival gastric cancer neopterin chitotriosidase stadialisation resectability intrahepatic cholangiocarcinoma hepatocellular carcinoma secondary tumor needle biopsy immunohistochemistry CK7 intratumoral immune cells saliva biomarkers anti-epileptic drugs therapeutic drug monitoring seizure epilepsy histopathology biomarker severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease (COVID-19) autopsy lung multiple sclerosis neurodegeneration clinically isolated syndrome optical coherence tomography retinal fiber layers ganglion cell layer posterior pole analysis macular retinal segmentation pulse wave velocity chronic kidney disease malnutrition inflammation triiodothyronine prolactin COPD COVID-19 SARS-CoV-2 infection predictive model mortality intensive care unit mechanical ventilation adropin kidney transplant recipients nutritional status body composition inflammatory markers machine learning transcatheter aortic valve replacement nasopharyngeal cancer tooth extraction glucose C-reactive protein albumin n/a thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology::MKGW Psychopharmacology |
| topic_facet | inflammation monocyte GLUT1 PET-CT scan non-small cell lung cancer prognosis survival gastric cancer neopterin chitotriosidase stadialisation resectability intrahepatic cholangiocarcinoma hepatocellular carcinoma secondary tumor needle biopsy immunohistochemistry CK7 intratumoral immune cells saliva biomarkers anti-epileptic drugs therapeutic drug monitoring seizure epilepsy histopathology biomarker severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease (COVID-19) autopsy lung multiple sclerosis neurodegeneration clinically isolated syndrome optical coherence tomography retinal fiber layers ganglion cell layer posterior pole analysis macular retinal segmentation pulse wave velocity chronic kidney disease malnutrition inflammation triiodothyronine prolactin COPD COVID-19 SARS-CoV-2 infection predictive model mortality intensive care unit mechanical ventilation adropin kidney transplant recipients nutritional status body composition inflammatory markers machine learning transcatheter aortic valve replacement nasopharyngeal cancer tooth extraction glucose C-reactive protein albumin n/a thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology::MKGW Psychopharmacology |
| url | ONIX_20240514_9783725806928_426 |